Winnow provides a daily probiotic supplement designed to bind microplastics within the digestive tract. Its patent-pending formulation of specific probiotic strains and prebiotic fiber supports gut health and helps mitigate internal microplastic accumulation from environmental exposure.
Funding
Funding not disclosed
Founders
Product
Problem
Microplastic contamination is a pervasive environmental issue, with particles increasingly detected in food, water, and air, leading to potential health concerns. Current mitigation strategies are often complex or insufficient for addressing daily exposure.
Solution
Winnow offers a daily probiotic supplement formulated with a patent-pending blend of probiotic strains designed to bind microplastics within the digestive tract. This approach aims to support gut health and mitigate the internal accumulation of microplastics from environmental exposure. The supplement is composed of naturally sourced ingredients, including specific probiotic strains and prebiotic fiber, encapsulated in a vegan capsule. By integrating this into a daily wellness routine, consumers can proactively address microplastic exposure.
Target Audience
The primary target audience includes health-conscious consumers seeking to manage environmental exposures and support their digestive and overall well-being.
Features
- Patent-pending probiotic formulation engineered for microplastic binding in vitro.
- Contains a blend of _Lactobacillus_, _Lactococcus_, and _Bifidobacterium_ species, recognized as GRAS (Generally Recognized as Safe) by the FDA.
- Demonstrated binding capabilities for polyethylene terephthalate (PET), polyethylene (PE), polypropylene (PP), polyvinyl chloride (PVC), and polystyrene (PS) microplastics in laboratory simulations.
- Includes prebiotic fiber to support a balanced gut microbiome.
- Formulated with all-natural ingredients, free from synthetic additives.
- Packaged in a plastic-free, reusable amber glass jar.
- Each dose provides 40 billion Colony Forming Units (CFU).